1 Pharmacokinetics: Introduction Dr Mohammad Issa.

Slides:



Advertisements
Similar presentations
Instant Clinical Pharmacology E.J. Begg
Advertisements

PHARMACOKINETIC.
III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
1 PK/PD modeling within regulatory submissions Is it used? Can it be used and if yes, where? Views from industry 24 September 2008.
Pharmacokinetics as a Tool
PHT 415 BASIC PHARMACOKINETICS Course Instructor:Prf. Dr. Hnaa elsaghir Assistant lecturers, Doaa elshora and eman elfakih Text: Hand book of basic pharmacokinetics,
Dosage Regimen Design in Patients with Renal Insufficiency Cont’d Pharmacy 732 Winter, 2001.
Nonlinear pharmacokinetics
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 25 Drug Interactions.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Clinical Pharmacy Part 2
University of Jordan-Faculty of Pharmacy
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
PHT 415 BASIC PHARMACOKINETICS
Pharmacokinetics Introduction
Concepts and Applications of Pharmacokinetics
Orientation to Pharmacology
1 Applied Pharmacokinetics of Antiepileptic Drugs (AEDs) B. Gitanjali Gitanjali-21:
Bioavailability Dr Mohammad Issa.
FARMAKOKINETIKA. INTRODUCTION Historically, pharmaceutical scientists have evaluated the relative drug availability to the body in vivo after giving a.
Biopharmaceutics refers to the relationship of the:
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
Core Concepts in Pharmacology Chapter 5 Pharmacokinetics.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Bioequivalence Dr Mohammad Issa Saleh.
CLINICAL PHARMACOKINETICS OF LIDOCAINE
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Bioavailability Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
PHARMACEUTICS- IV (PHT 414 ) Dr. Mohammad Khalid Anwer SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L111/16/2016.
INTRODUCTION CLINICAL PHARMACOKINETICS
Introduction of Biopharmaceutics and Pharmacokinetics
Design of Sustained Release Dosage Forms
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
Introduction to Pharmacology Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology.
Study Aids Anki Flash cards – Content that you need to know for the tests. MS Excel sheet with Calculations.
PHT 415 BASIC PHARMACOKINETICS
The General Concepts of Pharmacokinetics and Pharmacodynamics
415 PHT Plasma Level – Time Curve
1 Biopharmaceutics Dr Mohammad Issa Saleh. 2 Biopharmaceutics Biopharmaceutics is the science that examines this interrelationship of the physicochemical.
Donepezil. Donepezil Generic name: Donepezil. Brand name: Aricept. Chemistry: Donepezil hydrochloride is a piperidine derivative. It is a white crystalline.
Learning objectives To know what data is available from pharmacokinetic studies in man and how to handle it To know how to calculate the basic pharmacokinetic.
1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.
INTRODUCTION TO PHARMACOKINETICS M. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague, Charles University in Prague,
Definitions and Concepts
Introduction to Biopharmaceutics and Pharmacokinetics
Drug Response Relationships
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Chapter 9 PHARMACOKINETICS VARIABILITY
Applications of Pharmacokinetics
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
Controlled drug release
BTP3822 BIOPHARMACEUTICS by
Lab-3 practical pharmacology
Understanding the Basics of Pharmacology
Biopharmaceutics Dr Mohammad Issa Saleh.
Pharmacokinetics & pharmacodynamcs
Orientation to Pharmacology
Clinical Pharmacokinetics
Pharmacokinetics and Factors of Individual Variation
CTD Module 4: Non-Clinical Studies SPC Relevant Scientific information
Clinical Pharmacokinetics
Clinical Pharmacokinetics
1 Concentration-time curve
Therapeutic Drug Monitoring chapter 1 part 1
Introduction to Pharmacology
Biopharmaceutics and pharmacokinetic by: Anjam Hama A. M. Sc
Selvadurai Muralidharan, Kalaimani Jaya Raja Kumar
Presentation transcript:

1 Pharmacokinetics: Introduction Dr Mohammad Issa

2 What is pharmacokinetics?  Pharmacokinetics is the study of kinetics of absorption, distribution, metabolism and excretion (ADME) of drugs and their corresponding pharmacologic, therapeutic, or toxic responses in man and animals’’ (American Pharmaceutical Association, 1972).

3 Review of ADME processes  ADME is an acronym representing the pharmacokinetic processes of: A  Absorption D  Distribution M  Metabolism E  Excretion

4 Review of ADME processes  Absorption is defined as the process by which a drug proceeds from the site of administration to the site of measurement (usually blood, plasma or serum)  Distribution is the process of reversible transfer of drug to and from the site of measurement (usually blood or plasma)

5 Review of ADME processes  Metabolism is the process of a conversion of one chemical species to another chemical species  Excretion is the irreversible loss of a drug in a chemically unchanged or unaltered form  Metabolism and excretion processes represent the elimination process

6

7 Applications of pharmacokinetics  bioavailability measurements  effects of physiological and pathological conditions on drug disposition and absorption  dosage adjustment of drugs in disease states, if and when necessary  correlation of pharmacological responses with administered doses  evaluation of drug interactions  clinical prediction: using pharmacokinetic parameters to design a dosing regimen and thus provide the most effective drug therapy

8 Applications of pharmacokinetics Bioavailability measurements: Blood sulfadiazine concentration in human following the administration of a 3 g dose. A comparison of the behavior of microcrystalline sulfadiazine with that of regular sulfadiazine in human

9 Applications of pharmacokinetics Effects of physiological and pathological conditions on drug disposition and absorption: plasma conc-time profile of cefepime after a 1000 mg IV infusion dose

10 Applications of pharmacokinetics Using pharmacokinetic parameters to design a dosing regimen and thus provide the most effective drug therapy

11